Designs and engineers fluid delivery subsystems for semiconductor capital equipment. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
This company is not turning a profit, so the market is pricing its sales instead: 2.1× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 44% of them.
Analysts' average target sits 67% above today's price.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.
Clearly below the class average.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Growth: Sales growth trails the sector average.
Business Quality: Profit power and business quality trail similar companies in the sector.
The stock trades 49% below its peak. The market has trimmed its expectations for the company.
The company sells $947.7M a year; the problem isn’t sales — it’s costs running above that number.
A loss of $52.8M against $947.7M in annual sales.
At the current pace of spending, the cash lasts about 1.9 years. After that, the company needs to find new money.
Over the last 12 months, executives reported 59 sells against just 16 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, ICHR sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ICHR’s sales are going backwards, and it closed last year at a loss. The road back runs through both.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Analysts’ average target sits above today’s price, yet the valuation grade (44/100) says the stock isn’t cheap.
Not covered, because the filings we hold do not carry it: the revenue breakdown.